Purple glove syndrome: a complication of intravenous phenytoin
- PMID: 1289432
- DOI: 10.1097/01376517-199212000-00011
Purple glove syndrome: a complication of intravenous phenytoin
Abstract
Intravenous phenytoin, available for use since 1956, has several well known adverse effects, such as hypotension, arrhythmias and toxicity. Purple glove syndrome is a less common complication that can have serious consequences. Fasciotomies, amputations and permanent disuse of the hand and forearm have been reported. The etiology of purple glove syndrome is still unknown, but possible etiologies and risk factors have been suggested. Three stages of purple glove syndrome have been identified: appearance, progression and resolution. During the second stage, progression, purple glove syndrome can be identified as either mild or severe. Mild cases may heal uneventfully when nursing measures such as elevation, application of dry, gentle heat and measures to prevent secondary injury are instituted. Severe cases may require emergency surgical intervention such as fasciotomy to relieve pressure and restore blood flow. Therapeutic nursing interventions aimed at maximizing healing and promoting comfort are essential.
Similar articles
-
Purple Glove Syndrome after Phenytoin or Fosphenytoin Administration: Review of Reported Cases and Recommendations for Prevention.J Med Toxicol. 2015 Dec;11(4):445-59. doi: 10.1007/s13181-015-0490-z. J Med Toxicol. 2015. PMID: 26135797 Free PMC article. Review.
-
Purple glove syndrome associated with intravenous phenytoin administration in a patient with severe mental and motor retardation.J Orthop Sci. 2006 Jul;11(4):409-11. doi: 10.1007/s00776-006-1024-y. J Orthop Sci. 2006. PMID: 16897209 No abstract available.
-
Intravenous phenytoin and percutaneous arterial cannulation: the purple-glove syndrome.Eur J Anaesthesiol. 2007 Oct;24(10):900-1. doi: 10.1017/s0265021507001007. Eur J Anaesthesiol. 2007. PMID: 17977106 No abstract available.
-
Early histopathologic changes in purple glove syndrome.J Cutan Pathol. 2004 Aug;31(7):513-5. doi: 10.1111/j.0303-6987.2004.00224.x. J Cutan Pathol. 2004. PMID: 15239684
-
Recognizing and managing purple glove syndrome.Crit Care Nurse. 2000 Jun;20(3):54-61. Crit Care Nurse. 2000. PMID: 11876214 Review. No abstract available.
Cited by
-
Purple Glove Syndrome: Recognizing a Rare Complication of Intravenous Phenytoin.Cureus. 2022 Apr 8;14(4):e23958. doi: 10.7759/cureus.23958. eCollection 2022 Apr. Cureus. 2022. PMID: 35547441 Free PMC article.
-
An anaesthesiologist's encounter with purple glove syndrome.Indian J Anaesth. 2016 Mar;60(3):199-201. doi: 10.4103/0019-5049.177864. Indian J Anaesth. 2016. PMID: 27053784 Free PMC article.
-
Phenytoin-Induced Purple Glove Syndrome: A Case Report and Review of the Literature.Hosp Pharm. 2015 May;50(5):391-5. doi: 10.1310/hpj5005-391. Hosp Pharm. 2015. PMID: 26405326 Free PMC article.
-
Purple Glove Syndrome after Phenytoin or Fosphenytoin Administration: Review of Reported Cases and Recommendations for Prevention.J Med Toxicol. 2015 Dec;11(4):445-59. doi: 10.1007/s13181-015-0490-z. J Med Toxicol. 2015. PMID: 26135797 Free PMC article. Review.
-
Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers.Eur J Drug Metab Pharmacokinet. 2013 Jun;38(2):139-48. doi: 10.1007/s13318-012-0105-x. Epub 2012 Sep 12. Eur J Drug Metab Pharmacokinet. 2013. PMID: 22968854 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources